frost
-
Leukocare receives Frost & Sullivan’s biotechnology investment opportunity award
Leukocare has been awarded 2011’s Biotechnology Investment Opportunity Award by Frost & Sullivan.
frost | 30 March 2012
-
Ergonex Pharma Receives Award from Frost & Sullivan
Ergonex Pharma has received the “European Orphan Diseases Entrepreneurial Company Award†at the Frost & Sullivan's 2009 Excellence in Healthcare Awards Banquet, held in London, UK. The award was presented to the company in recognition of its inn…
frost | 01 November 2009
-
DB Schenker Rated as Preferred Service Provider in Pharmaceutical Logistics
DB Schenker has been named as the Pharmaceutical Logistics Service Provider of the Year (Singapore) for the fourth consecutive year. “This achievement further reaffirmed its position as the preferred logistics service provider for the pharmaceu…
frost | 26 August 2009
-
Frost & Sullivan Sees Opportunities in Chinese Vaccine Industry
With the outbreak of H1N1 influenza in several countries, people are aware of the importance of vaccine. According to Frost & Sullivan's research in the Chinese vaccine market, the Compound Annual Growth Rate (CAGR) of the pharmaceutical industry…
frost | 26 June 2009
-
Frost & Sullivan Awards Asia Pacific Companies
Frost & Sullivan presented 20 awards to the best companies in Asia Pacific’s Healthcare sector at the Asia Pacific Excellence in Healthcare Awards held at the InterContinental hotel in Singapore. Held for the fourth consecutive year, the a…
frost | 01 June 2009
-
Moleac Wins Frost & Sullivan Healthcare Award
Moleac has been named the Singapore Entrepreneurial Company of the Year by Frost & Sullivan. This award recognizes companies that have pushed the boundaries of excellence in the healthcare industry. The judging panel looked at market performance…
frost | 23 April 2009
-
Applied Biosystems Receives Award
Applied Biosystems has been selected for the Frost and Sullivan 2008 Vertical Market Penetration Leadership Award for the European Laboratory Information Management Systems (LIMS) market. The award was presented in recognition of innovation for t…
frost | 14 April 2009
-
Growth Opportunities for Pharmaceuticals and Healthcare Industry
The credit crisis and global economic meltdown have contributed to a significant shift in the healthcare industry in 2009. Healthcare in Asia Pacific will not be affected as severely as the developed countries, according to Frost & Sullivan. Dr Lo…
frost | 18 February 2009
-
Cashing in on orphan drugs
While most big pharmaceutical and biotechnology companies have traditionally depended on blockbuster molecules, it is estimated that $90.0 billion worth of ethical molecules will come off patent during 2007-2012. The industry is therefore conside…
frost | 19 November 2008
-
Report says innovation and strong therapeutic potential seen in adult stem cells
An increased number of diseases that are either incurable or difficult to treat allures clinicians to the approach of stem cell therapy. Highly prized, due to their therapeutic potential, stem cell therapies are believed to treat a wide variety o…
frost | 30 October 2008
